查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1145975

微生物鑑定市场 - COVID-19 的增长、趋势、影响和预测（2022-2027 年）

Microbial Identification Market - Growth, Trends, and Forecasts (2022 - 2027)
出版日期: | 出版商: Mordor Intelligence | 英文 114 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计微生物鑑定市场在预测期内的复合年增长率为 7.0%。

COVID-19 爆发对市场产生了重大影响。裁员减少了进出口活动，诊断中心和医院已经关闭。例如，根据 2021 年 9 月发表的论文《COVID-19 大流行对抗菌素耐药性的监测、预防和控制的影响：一项全球调查》，护理、医疗和公共卫生人员减少了 71% ，分别为 69% 和 64%。然而，随着 COVID-19 限制的解除以及行业诊断和测试服务的恢復，预计研究中的市场将在预测期内增长。

推动市场增长的特定因素包括传染病负担的增加、微生物鑑定的技术进步、食品安全问题的增加以及政府为促进微生物鑑定而采取的举措和资金。

传染病的日益流行是推动市场增长的关键因素。例如，根据世界卫生组织发布的《2021年全球结核病报告》的数据，大多数结核病病例发生在东南亚（43%）、非洲（25%）和西太平洋（18%）。东地中海（8.3%）、美洲（3.0%）和欧洲（2.3%）报告的肺结核病例数较低。同样，根据世界卫生组织 (WHO) 2021 年发布的数据，撒哈拉以南非洲地区继续承受疟疾负担，约占所有病例的 95% 和所有死亡人数的 96%。因此，越来越多的传染病病例将增加对微生物鑑定的需求，预计市场将出现高速增长。

此外，包装和未包装食品中日益增加的食品安全问题也促进了市场增长。如今，人们正在转向食用微生物污染风险更高的加工食品。例如，2020年12月，Nutrition and Diabetes发表了一篇题为《澳大利亚成年人口中的超加工食品消费与肥胖问题》的论文，发现他食用快餐菜餚、甜包子、包子、蛋糕等加工食品, 和垃圾食品。因此，此类加工食品的高消费预计将增加对微生物鑑定的需求，以向公众提供安全和优质的食品。

此外，世界卫生组织 2022 年 5 月发布的数据显示，每年估计有 6 亿人因食用受污染的食物而生病，并有 42 万人死亡。在低收入和中等收入国家，不安全食品每年造成 1100 亿美元的生产力损失和医疗保健费用。因此，食品污染髮生率的上升增加了对食品检测以检测特定致病微生物的需求。

此外，2020 年，世界卫生大会呼吁世界卫生组织报告到 2025 年全球食源性疾病负担的最新发病率、死亡率和疾病负担估计值。通过了一项新决议。该决议授权世卫组织在国家、区域和国际各级监测食源性疾病和人畜共患病的全球负担。这些政府举措也有助于市场的增长。

但是，在预测期内，自动化微生物识别系统的高成本可能会阻碍市场增长。

主要市场趋势

仪器推动产品和服务领域的增长

由于传染病负担增加、微生物鑑定意识增强以及技术先进产品的出现等因素，预计设备细分市场在预测期内将出现显着增长。

多年来，可识别生物的范围已扩大到包括更广泛的微生物菌株。这包括使用质谱 (MS) 从临床标本中快速识别分离细菌的技术。

随着传染病的流行，越来越需要识别导致它们的微生物。例如，根据世界卫生组织2022年7月公布的数据，加纳阿散蒂地区报告了两例马尔堡病毒病（MVD）死亡病例，随后马尔堡病毒检测呈阳性。此外，2022 年 4 月发布的消息表明，佛罗里达州爆发了 C 群脑膜炎球菌病，主要发生在与其他男性发生性关係的男性中，包括 HIV 阳性的男性。据信具有影响力。

此外，企业在微生物鑑定产品开发方面的活动不断增加，预计也将在预测期内推动细分市场的增长。例如，2021 年 7 月，布鲁克公司将为其 MALDI Biotyper (MBT) 平台推出一种新产品和方法，即 MALDI Biotyper Sirius，用于从培养板和阳性血培养中进行快速、近乎通用的“蛋白质组指纹”。并支持具有成本效益的微生物鑑定工作流程。同样在 2021 年 4 月，生物梅里埃的下一代 MALDI-TOF 质谱系统 VITEK MS PRIME 获得了 CE 标誌，可在几分钟内进行常规微生物鑑定。

因此，由于上述因素，预计该市场将在预测期内增长。

北美市场份额最大

由于传染病和流行病的爆发、医疗保健成本上升以及已建立的医疗保健基础设施的存在等因素，预计北美将在预测期内主导微生物鑑定市场。

该地区的传染病流行已成为推动市场增长的关键因素。

根据医疗保险和医疗补助服务中心于 2022 年 3 月发布的题为“精算师 CMS 办公室发布的 2021-2030 年国家卫生支出预测”的数据，2021 年至 2030 年国家卫生支出的年增长率预计为平均 5.1%。 2020年，全国医疗保健支出为4.1万亿美元，预计2030年将达到6.8万亿美元。因此，预计增加医疗保健支出将增加企业活动和政府在开发技术先进的测试产品和仪器方面的举措，从而推动市场增长。

此外，技术先进产品的兴起和该地区主要市场参与者的存在也有望在预测期内推动市场增长。例如，2022 年 1 月，BD Kiestra IdentifA 系统获得了美国食品和药物管理局的 510(k) 许可，该系统旨在自动化微生物细菌鑑定测试的准备工作。同样在 2021 年 1 月，布鲁克将推出 MBT Sepsityper Kit US IVD，用于从 MALDI Biotyper CA 系统上的阳性血培养物中快速鑑定超过 425 种生物体。

因此，由于上述因素，研究中的市场预计将在预测期内增长。

竞争格局

这个市场既有全球公司，也有本地公司，所以竞争很低。一些公司目前在市场上占有健康的份额。例如，Thermofisher Scientific、BioMerieux SA、Beckman Coulter Inc.、Shimadzu Corporation、Becton、Dickinson and Company 是市场的主要参与者，还有拥有大量份额的本地和中小企业。

其他特典

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第 1 章介绍

  • 研究假设和市场定义
  • 调查范围

第 2 章研究方法

第 3 章执行摘要

第 4 章市场动态

  • 市场概览
  • 市场促进因素
    • 增加传染病负担
    • 微生物鑑定技术进展
    • 对食品安全的担忧日益增加
    • 政府为促进微生物检测所做的努力和资助
  • 市场抑制因素
    • 自动微生物鑑定系统成本高
  • 波特五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（基于价值的市场规模：百万美元）

  • 按产品/服务
    • 设备
    • 消耗品
    • 按服务
  • 按方法
    • 表型法
    • 基因分型方法
    • 基于蛋白质组学的方法
  • 按应用
    • 诊断
    • 食品和饮料检验
    • 药品
    • 化妆品和个人护理产品检验
    • 其他应用
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东和非洲
      • 海合会
      • 南非
      • 其他中东和非洲
    • 南美洲地区
      • 巴西
      • 阿根廷
      • 其他南美洲

第 6 章竞争格局

  • 公司简介
    • Becton, Dickinson and Company
    • Biolog Inc.
    • BioMerieux SA
    • Bruker Corporation
    • Charles River Laboratories International Inc.
    • Danaher Corporation（Beckman Coulter Inc.）
    • Eurofins Scientific SE
    • Merck Millipore（Merck KGaA）
    • Shimadzu Corporation
    • Thermo Fisher Scientific Inc.
    • VWR Corporation

第 7 章市场机会和未来趋势

简介目录
Product Code: 64219

The Microbial Identification Market is projected to witness a CAGR of 7.0% over the forecast period.

The COVID-19 outbreak has had a significant impact on the market. As employment closures have curtailed import and export activities and closures of diagnostics centers and hospitals. For instance, according to an article titled "Impact of the COVID-19 pandemic on the surveillance, prevention, and control of antimicrobial resistance: a global survey" published in September 2021, there was a reduction in the availability of the nursing, medical, and public health staff for antimicrobial resistance by 71%, 69%, and 64%, respectively. However, with the release COVID-19 restrictions and resumed diagnosis and testing services in industries the studied market is expected to grow over the forecast period.

Certain factors propelling the market growth are the rising burden of infectious diseases, technological advancements in microbial identification, increasing food safety concerns, and government initiatives and funding for promoting microbial identification.

The increasing prevalence of infectious diseases is the key factor driving market growth. For instance, according to the data published by the World Health Organization in the Global Tuberculosis Report 2021, most of the tuberculosis cases were found in the World Health Organization (WHO) regions of South-East Asia (43%), Africa (25%) and the Western Pacific (18%), and lesser numbers of tuberculosis cases were found in Eastern Mediterranean (8.3%), the Americas (3.0%) and Europe (2.3%). Similarly, according to the World Health Organization (WHO) data published in 2021, Sub-Saharan Africa likely continues to endure the burden of malaria, accounting for approximately 95% of all cases and 96% of all deaths. Thus, rising cases of infectious diseases are expected to increase the demand for microbial testing resulting in the high growth of the market.

Additionally, the growing food safety concerns in packed and non-packed food are also contributing to the market growth. The population nowadays is more shifting toward consuming processed foods which have a high risk of microbial contamination. For instance, according to an article published by Nutrition and Diabetes, in December 2020, titled 'Ultra-processed food consumption and obesity in the Australian adult population", it has been found that 80% of the adults in Australia consumed processed or junk food, such as mass-produced packaged bread, ready meals, fast food dishes and pastries, buns and cakes, in their daily life. Thus, the high consumption of this processed food by the population is expected to increase the demand for microbial testing to deliver safe and quality food to the population.

Furthermore, as per the data published by the World Health Organization in May 2022, an estimated 600 million people fall ill eating contaminated food and 420 000 die every year. In addition, USD 110 billion is lost each year in productivity and medical expenses resulting from unsafe food in low- and middle-income countries.Thus, the rising incidences of food contamination has increased the need for food testing for detecting specific microbes causing diseases.

Moreover, in 2020, the World Health Assembly passed a new resolution requiring the World Health Organization to report on the global burden of foodborne diseases by 2025 with the most recent estimates of incidence, mortality, and disease burden. The resolution mandates WHO to monitor the global burden of foodborne and zoonotic diseases at national, regional, and international levels. Such initiatives by the government are also contributing to market growth.

However, the high cost of automated microbial identification systems is likely to impede the market growth over the forecast period.

Key Market Trends

Instruments are Driving the Product and Service Segment's Growth

The instrument segment is expected to witness significant growth in the studied market over the forecast period owing to the factors such as the rising burden of infectious diseases, growing awareness regarding microbial testing, and emerging technologically advanced products.

The range of the distinguishable organism has expanded over the years to include a wider range of microorganism strains. These include techniques for rapid isolated-organism identification using mass spectrometry (MS) in clinical specimens.

With the increasing prevalence of infectious diseases, there is an increasing need to identify the microorganism causing them. For instance, as per the World Health Organization data published in July 2022, two fatal cases of Marburg virus disease (MVD) were reported from the Ashanti region, Ghana, and were later tested positive for Marburg virus. Additionally, as per a news published in April 2022, in Florida, there has been a significant serogroup C meningococcal disease outbreak, mostly affecting men who have intercourse with other men, including those who are HIV-positive.

Additionally, the rising company activities in developing microbial testing products are also expected to boost segment growth over the forecast period. For instance, in July 2021, Bruker Corporation launched new products and methods for the MALDI Biotyper (MBT) platform, MALDI Biotyper Sirius, that supports workflows for the rapid, nearly universal and cost-effective microbial identification by 'proteomic fingerprinting' from culture plates and from positive blood cultures. Also, in April 2021, bioMerieux received CE-marking of VITEK MS PRIME, the next generation of the VITEK MS MALDI-TOF mass spectrometry system for routine microbial identification in minutes.

Thus, owing to the aforementioned factors, the studied market is expected to grow over the forecast period.

North America Accounts for the Largest Share in the Market

North America is expected to dominate the microbial identification market over the forecast period owing to the factors such as the rising burden of infectious diseases and outbreaks of epidemics, growing healthcare expenditure, and the presence of well-established healthcare infrastructure.

The increasing prevalence of infectious diseases in the region is the key factor fuelling the market growth. For instance,

As per the data published by the Centers for Medicare & Medicaid Services, in March 2022, titled "CMS Office of the Actuary Releases 2021-2030 Projections of National Health Expenditures", it has been observed that the annual growth in national health spending is expected to be average 5.1% over 2021-2030. Also, the National Health Spending in 2020 was USD 4.1 trillion and it is projected to reach USD 6.8 trillion by 2030. Thus, the increasing healthcare spending is expected to increase company activities and government initiatives in developing technologically advanced testing products and equipment, thereby propelling the market growth.

In addition, rising technologically advanced products and the presence of key market players in the region are also expected to boost market growth over the forecast period. For instance, in January 2022, BD received 510(k) clearance from the United States Food and Drug Administration for BD Kiestra IdentifA system which is designed to automate the preparation of microbiology bacterial identification testing. Also, in January 2021, Bruker Corporation launched MBT Sepsityper Kit US IVD for rapid microbial identification of more than 425 microorganisms from positive blood cultures on the MALDI Biotyper CA System.

Thus, owing to the aforementioned factors, the studied market is expected to grow over the forecast period.

Competitive Landscape

The market studied is moderately competitive, with the presence of both global and local players. Few companies currently hold a healthy share of the market. For instance, Thermofisher Scientific, BioMerieux SA, Beckman Coulter Inc., Shimadzu Corporation, and Becton, Dickinson and Company are the major players in the market, along with local and smaller companies that hold a substantial share.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Burden of Infectious Diseases
    • 4.2.2 Technological Advancements in Microbial Identification
    • 4.2.3 Increasing Food Safety Concerns
    • 4.2.4 Government Initiatives and Funding for Promoting Microbial Identification
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Automated Microbial Identification Systems
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Products and Services
    • 5.1.1 Instruments
    • 5.1.2 Consumables
    • 5.1.3 Services
  • 5.2 By Method
    • 5.2.1 Phenotypic Methods
    • 5.2.2 Genotypic Methods
    • 5.2.3 Proteomics-based Methods
  • 5.3 By Application
    • 5.3.1 Diagnostics
    • 5.3.2 Food and Beverage Testing
    • 5.3.3 Pharmaceuticals
    • 5.3.4 Cosmetics and Personal Care Products Testing
    • 5.3.5 Other Applications
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Becton, Dickinson and Company
    • 6.1.2 Biolog Inc.
    • 6.1.3 BioMerieux SA
    • 6.1.4 Bruker Corporation
    • 6.1.5 Charles River Laboratories International Inc.
    • 6.1.6 Danaher Corporation (Beckman Coulter Inc.)
    • 6.1.7 Eurofins Scientific SE
    • 6.1.8 Merck Millipore (Merck KGaA)
    • 6.1.9 Shimadzu Corporation
    • 6.1.10 Thermo Fisher Scientific Inc.
    • 6.1.11 VWR Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS